Synthesis and evaluation of Ga-68 labeled somatostatin analogue DOTA-Pasireotide for tumor imaging.

fei liu,hua zhu,xinfeng lin,chiyi xiong,chun li,zhi yang

2015-01-01

Journal of Nuclear Medicine

Abstract:1113 Objectives The purpose of this work was to develop a new somatostatin analogue for tumor noninvasive PET imaging. Although Octreotide has been widely used for somatostatin receptor positive tumors, it only has a high affinity of SSTR 2 among the five somatostatin receptors[1, 2].Recently, Pasireotide was reported to have a better binding affinity of SSTR 1, 3, 5 and similar affinity of SSTR 2 compared with Octreotide [3, 4]. Herein, we developed novel Ga-68 labeled DOTA-Pasireotide for PET imaging of somatostatin receptor positive tumors. Methods The cyclic peptide amide DOTA-Pasireotide coupled with bifunctional chelating agent (p-SCN-Bn-DOTA) was synthesized and radiolabeled with 68Ga to yield 68Ga-DOTA-Pasireotide PET probe. The samples Pasireotide and DOTA-Pasireotide were analysed by liquid chromatography-mass spectrometry (LC-MS) before radiolabeling and the 68Ga labeled compounds were determained by radio-HPLC (Figure.1). The precursor DOTA-Pasireotide was labeled with Ga-68 in sodium acetate buffer (pH 4.0) by heating at 100 °C for 20 min. After purification, 12.95 MBq of 68Ga-DOTA-Pasireotide was injected intravenously to BALB/c nude mice bearing human HT29 colon tumors via tail vein. The PET images were taken 2 and 4 hours after radiotracer injection. Results 68Ga was radiolabeled with DOTA-Pasireotide in 98% radiochemical purity as determined by radio-HPLC. In vitro stability experiments showed in 2 hours 68Ga-DOTA-Pasireotide was stable in 5% human serum, NaAc (pH 5.5) and PBS (pH 7.4). In vivo, the HT29 cell xenograft tumors uptake of 68Ga-DOTA-Pasireotide was clearly visualized by 4 h postinjection. Conclusions In this study, we described the synthesis and characterization of 68Ga labeled cyclic peptide 68Ga-DOTA-Pasireotide. We found that 68Ga-DOTA-Pasireotide could be taken up by HT29 cell exonograft tumors. In brief, the somatostatin analogue 68Ga-DOTA-Pasireotide may be useful for imaging somatostatin receptor positive tumors. Research Support Supported by grant #81172083, grant #81371592 and grant #81401467 from the National Natural Science Foundation of China and by #7132040 from the Beijing Municipal Natural Science Foundation of China.